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Objective: To evaluate the use of Ceiba pentandra (C. pentandra) as a glucose lowering
agent and the attendant physiological changes in albino rats.
Methods: Acute oral toxicity study of the extract was carried out by the administration
of 10, 100, 1000, 1600, 2900, and 5000 mg/kg body weight of C. pentandra to rats in
their respective groups. Twenty healthy albino rats weighing between 140 and 150 g were
randomly allotted to ﬁve groups of four rats each. 100 mg/kg body weight of alloxan
monohydrate was i.p. administered to rats and rats with blood glucose  200 mg/dL were
considered diabetic. 5 mg/kg body weight of standard drug, 200 and 400 mg/kg body
weight of ethanol extract of C. pentandra were orally administered to diabetic rats in their
respective groups once daily for 12 days while the control groups received 0.1 mL of
normal saline for the same period. The blood glucose was checked after every 4 days and
the experiment was terminated on the 17th day.
Results: The safe dose (LD50) of the extract was greater than 5000 mg/kg body weight.
The extract treated groups exhibited a remarkable reduction in blood glucose
[(87.72 ± 7.67) mg/dL for 200 mg/kg body weight dose and (86.33 ± 4.54) mg/dL for
400 mg/kg body weight dose] competitively with the normoglycemic group
[(88.71 ± 4.56) mg/dL]. The body weight of the extract and standard drug treated groups
appreciated signiﬁcantly (P < 0.05) as compared with normoglycemic group. High density
lipoprotein increased signiﬁcantly in the extract treated groups with the 400 mg/kg body
weight having the highest value of (18.61 ± 3.44) mg/dL and a concomitant reduction in the
concentrations of low density lipoprotein, triacylglycerol, and cholesterol of same group.
The 400 mg/kg body weight dose of the extract also demonstrated the highest reduction in
the activities of aspartate transaminase [(59.66 ± 3.45) IU/L], alanine aminotransferase
[(33.33 ± 4.34) IU/L] and alkaline phosphatase [(48.36 ± 3.41) IU/L] that elevated as a result
of diabetes. The two extract treated groups demonstrated a marked reduction in Cl−, and
elevation in HCO3
− and Na+ levels. K+, urea, creatinine, total and conjugated bilirubin that
were elevated in the diabetic untreated group were all ameliorated in the treatment groups.
Conclusions: Ethanol extract of C. pentandra has glucose lowering effect and can
ameliorate the biochemical abnormalities associated with diabetes mellitus.of Technology, Minna, Nigeria.
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Glucose is the most important controller of insulin secretion,
and insulin secretion is exerted by a feedback effect of blood
glucose on the b cell of the pancreas. When blood glucose
concentration rises above fasting levels, insulin secretion in-
creases and stimulates glucose uptake by the liver and the pe-
ripheral tissues thereby returning glucose to the normal levels.
This provides an important negative feedback mechanism for
controlling the blood glucose concentration. Diabetes mellitus is
a chronic disease due primarily to a disorder in carbohydrate
metabolism, as a result of deﬁciency or diminished effectiveness
of insulin, resulting in hyperglycemia and glycosuria[1]. Diabetes
affects more than 100 million people worldwide (6% of the
population) and in the next 10 years is projected to affect ﬁve
times more people than it does now[2]. The effects of diabetes
mellitus include long-term damage, dysfunction and failure of
various organs. The disease may present with classical charac-
teristic features such as blurring of vision, excessive thirst
(polydypsia), excessive feeding (polyphagia), excessive urina-
tion (polyuria), and weight loss. In its most severe form,
ketoacidosis may develop leading to stupor, coma and in
absence of effective treatment, death ensues[3]. In conventional
therapy, type 1 diabetes is treated with exogenous insulin,
while type 2 is treated with oral hypoglycemic agent like
biguanides and sulphonylureas[4]. Although these agents
provide a good glycemic control, they can do little to prevent
secondary complications. Besides, they are also associated
with side-effects or diminution in response after prolonged
use[5]. According to World Health Organization (WHO)[6], more
than 80% of the world population depends on the traditional
medicine for their primary health care and this practice is
recommended especially in countries where access to
conventional treatment of diabetes is inadequate. WHO
however emphasizes the fact that safety should be an
overriding criterion in the selection of herbal medicine for the
use in health care programme. The medicinal potentials of
Ceiba pentandra (C. pentandra) may be due to the presence
of bioactive compounds (secondary metabolites) that produce
deﬁnite physiological action in the human body. They are
produced by speciﬁc parts of the plant and translocated to
other parts for storage[7]. Alloxan is a cytotoxic glucose
analogue widely used to induce diabetes in experimental
animal models. It destroys the pancreatic b-cells with speciﬁc
selectivity and produces selective necrosis of b-cells of islets
of Langerhans when injected into animals[8].
C. pentandra Telugu: is a tropical tree of the order Malvales
and the family Malvaceae (previously separated from the family
Bombacaceae). It is native to Mexico, Central America and the
Caribbean, North-South America, and tropical West Africa[9].
Kapok is the most used common name for the tree and may
also be referred to the cotton-like ﬂuff obtained from its seed
pods. The tree is also known as the Javacotton, Java kapok, silk-
cotton or ceiba. Its bark decoction has been used as a diuretic,
aphrodisiac, and to treat headache, as well as type II diabetes. It
is used as an additive in some versions of the hallucinogenic
drink[10]. Diabetes and its associated complications have become
a public health problem of considerable magnitude and is one of
the top ﬁve global leading causes of death. In the year 2000, the
excess global mortality attributable to diabetes and its late
complications were estimated to be 2.9 million deaths,
equivalent to 5.2% of all deaths. The unaffordability and sideeffects associated with the conventional antidiabetic drugs
have resulted in increased search for alternative medicinal
plants. The side effects of the new agent, and its ameliorative
potentials on complications associated with diabetes will also
be investigated.
2. Materials and methods
2.1. Reagents and chemicals
All the reagents used for the research were of analytical grades
and obtained from the Department of Biochemistry, Federal
University of Technology, Minna, Nigeria. They include distilled
water, ethanol, Randox diagnostic kits and normal saline.
2.2. Apparatus and equipment
These include: reﬂux extractor, milling machine, rotary
evaporator, bucket centrifuge, water bath, Whatman ﬁlter paper,
measuring cylinders, hand gloves, masking tape, beakers, sy-
ringes, spatula, glucometer, and weighing balance.
2.3. Sample collection
2.3.1. Plant sample
Adequate quantities of fresh leaves of C. pentandra were
collected in July, 2015 from rural area of Gada Oli via Wawa,
New-Bussa, Niger State, Nigeria and were identiﬁed and
authenticated at the Herbarium of Department of
Biological Sciences, Federal University of Technology, Minna,
Nigeria.
2.3.2. Preparation of plant material
The leaves were washed, blotted and air-dried at room tem-
perature in the Departmental Laboratory for two weeks. They
were homogenized into ﬁne powder using milling machine.
2.3.3. Experimental animals
Healthy Swiss albino rats weighing 100–200 g were procured
from Animal house of Faculty of Pharmaceutical Sciences,
Ahmadu Bello University, Zaria, Kaduna State, Nigeria. The
animals were housed and accommodated in groups of four in
polypropylene cages with stainless steel grill top and a bedding of
clean paddy husk. Standard room temperature of 30–36 C, 12 h
light and dark cycles were also maintained. They were allowed
access to commercial grower mesh to feed on ad libitum. Accli-
matization of the animals to these conditions was for two weeks.
2.3.4. Extraction of plant sample
1500 g of dried powdered sample of C. pentandra was
weighed and extracted with 300 mL ethanol using reﬂux method
at temperature of 60 C. The extract was thereof concentrated
with rotary evaporator and then evaporated to dryness in a water
bath at 100 C. The crude extract yielded 130.11 g (9.29%) and
was stored in a labeled sterile bottle kept at 4 C in a refrigerator
until ready for use.
2.4. Acute toxicity studies
The acute toxicity test of the ethanol extract was carried out
by the method of Lorke[11]. Eighteen albino rats were fasted for
Table 1
Acute oral toxicity test of ethanol leaf extract of C. pentandra.
Phase 1 Phase 2
Dose (mg/kg body
weight)
Mortality Dose (mg/kg body
weight)
Mortality
10 0/3 1600 0/3
100 0/3 2900 0/3
1000 0/3 5000 0/3
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groups of three rats each and orally administered extract at
varied doses of 100, 150, 250, 1000, 2000 and 5000 mg/kg
body weight. The animals were monitored for 24 h to check
for convulsion, salivation, diarrhea, lethargy, sleep, coma,
nervousness and/or mortality.
2.5. Grouping of animals for glucose lowering test
The experimental design consisted of 20 rats grouped
as follows: Group 1 – Normoglycemic (positive control)
received 0.1 mL of normal saline; Group 2 – Diabetic un-
treated (negative control); Group 3 – Diabetic treated with
standard drug (5 mg/kg body weight of glibenclamide); Group
4 – Diabetic treated with 200 mg/kg body weight of crude
ethanol extract of C. pentandra and Group 5 – Diabetic treated
with 400 mg/kg body weight of crude ethanol extract of C.
pentandra.
2.6. Hyperglycemic rats
The blood glucose of rats was elevated by the administration
of 100 mg/kg body weight of alloxan monohydrate intraperito-
neally after an overnight fast but with access to drinking
water[12]. The animals were then housed in a controlled facility
and allowed to drink 5% glucose solution to overcome the
hypoglycemia[13]. The hyperglycemic state was conﬁrmed by
the measurement of fasting blood glucose concentration using
glucometer with blood collected by tail vein puncture. Rats
with blood glucose  200 mg/dL after 72 h were considered
diabetic and used for the research.
2.7. Treatment with extract and standard drug
Ethanol extract and glibenclamide (standard drug) were dis-
solved in 10 mL normal saline (0.9% NaCl) before oral
administration. Respective doses of extract and standard drug
were then administered to rats once daily (10 am) for twelve
days and the blood glucose was checked after every four days.
On the seventeenth day, the rats were fasted for 12 h and
euthanized. Blood samples were collected by carotid puncture
into heparinized tubes, centrifuged at 1000 r/min for 5 min and
the clear serum supernatant was used freshly for the assessment
of lipid proﬁle, liver, and kidney function tests. For the hema-
tological parameters, the blood was collected into EDTA test
tubes.
2.8. Serum biochemical parameters
The biochemical parameters that were investigated include:
alanine aminotransferase, aspartate aminotransferase, alkaline
phosphatase, total and conjugated bilirubin using Randox
diagnostic kits.
2.9. Hematological parameters
The full blood count including total red blood cell (RBC),
hemoglobin concentration (HGB), white blood cell count
(WBC), platelet count (PLT) and other hematological param-
eters were determined using Swelab Auto Hematology
Analyzer.2.10. Plasma lipid proﬁles
The plasma total cholesterol (TC), triglyceride (TG), high
density lipoprotein (HDL), and low density lipoprotein (LDL)
were determined using Randox diagnostic kits. The absorbance
was determined and calculated using Stat fax 4500 semi-
automated chemistry analyzer.
2.11. Liver and kidney function tests
Plasma enzyme-aspartate aminotransferase (AST), alkaline
phosphatase (ALP), alanine aminotransferase (ALT), total
protein, total bilirubin (BIL), creatinine, serum electrolytes (K+,
Cl−, HCO3
−, Na+) were determined using Randox diagnostic
kits.
2.12. Statistical analysis
SPSS software was used to analyze all the data. Results are
expressed as mean ± SEM using ANOVA, followed by
Turkey, Duncan and Dunnet's multiple comparison test and
the values of P < 0.05 were considered to be statistically
signiﬁcant.
3. Results
No behavioral changes such as alertness, motor activity,
breathlessness, restlessness, diarrhea, tremor, convulsion and
coma were observed at the administered doses. The rats were
physically active and no death was recorded even at the dose of
up to 5000 mg/kg body weight (Table 1). Therefore, the LD50 is
greater than 5000 mg/kg body weight.
Glucose concentrations decreased in all treated groups
compared with the untreated group that continued to elevate
until when all the animals were sacriﬁced. The 400 mg/kg
bodyweight had a better hypoglycemic effect (Figure 1).
The total body weight of rats in various groups appreciated as
the treatment progressed except the diabetic untreated group that
depreciated with the highest effect in standard drug treated group
followed by 400 mg/kg body weight extract treated group
(Figure 2).
All electrolytes were ameliorated by the administration
extract. The extract at both doses was able to correct the po-
tassium level in dose dependent manner as much as did the
standard drug (Figure 3) as compared with diabetic untreated
group.
Urea and creatinine that were signiﬁcantly elevated
(P < 0.05) in diabetic untreated group were signiﬁcantly reduced
when varied doses of extract and standard drug were orally
administered to rats in the treatment groups (Figure 4). In fact,
Figure 1. Effect of extract on glucose concentration.
Figure 3. Electrolytes levels of rats in groups.
Figure 4. Effect of extract on some kidney parameters.
Figure 5. Effect of extract on the activity of enzymes.
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similar urea and creatinine concentration at the end of
experiment.
The activities of AST, ALT and ALP that were signiﬁcantly
elevated (P < 0.05) in the diabetic untreated group were
signiﬁcantly reduced when varied doses of extract and standard
drug were orally administered to rats in the treatment groups
(Figure 5). While the ALT and ALP activities tend towards
normoglycemic group.
Total and conjugated bilirubin were elevated signiﬁcantly
(P < 0.05) while albumin and total protein decreased signiﬁ-
cantly in the untreated group. These anomalies were ameliorated
by the administration of the extract at 200 mg/kg body weight
and 400 mg/kg body weight (Figure 6). Similar effect of
improvement was also observed in standard treated group as
compared to diabetic untreated group.
HDL decreased, while LDL, TAG, and cholesterol all
increased in the untreated group as compared to with the extract
and standard drug treated groups (Figure 7). Administration of
extract at varied doses increased the HDL more than the standard
drug. LDL, TAG and cholesterol all decreased signiﬁcantly
(P < 0.05) when the animals were treated with the extract and
the standard drug.
Some hematological parameters (except MCH) decreased
signiﬁcantly (P < 0.05) in the diabetic untreated group, while the
WBC increased in the same group (Figure 8). Administration of
the extract at both doses (200 mg/kg body weight and 400 mg/kg
body weight) and the standard drug normalizes the level of RBC
and WBC. The positive effect was quite corresponding to the
normoglycemic group.Figure 2. Effect of extract on animals' body weight.
Figure 6. Effect of extract on some biochemical parameters.
D. bilirubin: Direct bilirubin; C. bilirubin: Conjugated bilirubin; T. Protein:
Total protein.
Figure 7. Effect of extract on lipids.
Figure 8. Effect of extract on hematological parameters.
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Blood glucose is a key marker for diagnosis and prognosis of
diabetes mellitus. The evaluation of hypoglycemic activity of
any agent using alloxan-induce hyperglycemia animal model has
been described by several authors that have used plant extracts
to monitor the blood glucose and the attendant abnormalities
associated with diabetes. Alloxan selectively destroy the
pancreatic b-cells of Langerhans that secrete insulin thereby
leaving the less active cells that leave the animal in a diabetic
state[14]. Treatment with ethanol extract of C. pentandra at 200
and 400 mg/kg body weight alleviated the hyperglycemic
condition of the diabetic rats to near normal as indicated by
the normoglycemic group. The 400 mg/kg body weight group
had a swift hypoglycemic effect with a reduction of 60.95%
the ﬁrst day the blood glucose was measured after the
establishment of the diabetic state (345 ± 4.56–182 ± 6.32).
Similar hypoglycemic property from plant extract was earlier
established by Frederick et al.[15]. The hypoglycemic property
of the ethanol extract of C. pentandra, may be by the
following mechanisms: that the extract has the ability to
inhibit the endogenous glucose production, interferes with
gastrointestinal glucose absorption, has insulin-like substances
(insulin mimetic), inhibits insulinase activity and increases the
secretion of insulin from the b-cells of pancreas[16]. It may also
be possible that the extract was able to increase the b-cells in
the pancreas by activating the regeneration of these cells or its
release from bound insulin.
The body weight of the two groups treated with ethanol
extract of C. pentandra increased as the treatment progressed in
days and as long as there was a de-elevation in blood glucose
(Table 1) with the 400 mg/kg body weight having a better
ameliorating effect. Weight loss is a clinical feature of diabetic
mellitus[17], probably due to excessive break down of tissueprotein and lipid and thus all animals in the diabetic groups
showed signiﬁcant weight loss fourth day after the
establishment of diabetes and a concomitant reversible of
weight loss days after the treatment commenced. The transient
gain in weight may be attributable to improved metabolic
activities and the maintenance of glucose homeostasis.
The kidneys regulate the excretion of urea and reabsorption
of electrolytes into the blood. Filtration occurs at the glomeruli
while reabsorption takes place in the renal tubules[18]. When
there is compromise of normal glomerular function, substances
normally cleared by the kidneys such as urea and creatinine
accumulate in the biological ﬂuid. The signiﬁcant increase in
serum urea, creatinine, chloride (hyperchloremia) and
potassium observed in diabetic untreated group suggests that
the normal excretion of these biomolecules and electrolytes by
the kidney was adversely affected. Furthermore, the decrease
in the levels of sodium and bicarbonate in diabetic untreated
group suggests that some aspects of tubular functioning as it
relates to these electrolytes have been compromised. The
bicarbonate ion acts as a buffer to maintain the normal acidity
in blood and other ﬂuids in the body. Disruptions in the
normal bicarbonate level may be due to diseases kidney or
metabolic conditions. Treatment of rats in the diabetic group
with ethanol leaf extract of C. pentandra and glibenclamide
resulted in signiﬁcant improvement in kidney function as
indicated by the marked decrease in serum sodium, potassium,
urea, and creatinine (that were elevated in diabetic group), and
an increase in bicarbonate and sodium (that were reduced in
diabetic group). Similar nephroprotective activities have been
reported for other medicinal plants such as Murraya
koenigii[4]. Ammonia released during deamination is removed
from the blood by conversion into urea. Urea is high when the
glomerular ﬁltration is high as seen in the diabetic untreated
group. Creatinine is ﬁltered in the glomerular ﬁltrate and
passes on through the tubular system and is excreted in the
urine. In kidney dysfunction, creatinine is reabsorbed rather
than excreted in urine. This may be the case with the diabetic
untreated group where creatinine level was high.
In assessing the hepatic status of animals (hepatoprotective or
hepatotoxicity) when medicinal plant extract is administered,
determination of serum alanine aminotransferase (ALT), serum
aspartate aminotransferase (AST), alkaline phosphatase (ALP),
albumin and total protein play a major role. The alteration in the
activities of these biomarkers as indicated in the diabetic un-
treated group (Figure 3) signiﬁes damages to the liver including
the biliary system. The elevated levels of the enzyme (ALT,
AST and ALP) could be as a result of inﬂammation of liver cell,
the enzymes leaking into the blood stream leading to a rise in
their levels (Figure 3). Alkaline phosphates (ALP) is particularly
a biomarker enzyme for assessing the integrity of plasma
membrane, and such increase in its activities can constitute
threat to the life of cells that are dependent on a variety of
phosphate esters for their vital process since there may be
indiscriminate hydrolysis of phosphate ester of the tissue[19].
Both doses of the C. pentandra (particularly the 400 mg/kg
body weight) compared favorably with the glibenclamide in
alleviating the high level observed in the diabetic untreated
group.
Diabetes mellitus is associated with altered protein meta-
bolism because much of structural proteins are used in gluco-
neogenesis. This is because insulin is an important
physiological factor that plays a key role in the maintenance of
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amino acids and protein synthesis, but also inhibits protein
degradation[20]. The decrease in total protein and albumin of the
diabetic untreated group could be as a result of continuing
utilization of protein and lipid as sources of energy and a
compromise of the synthetic ability of the liver.
Administration of ethanol leaf extract of C. pentandra
however, tends to shift the levels of albumin and total
protein to normal. This could be linked to the hypoglycemic
potentials of the extract that potentiate the activities of
insulin and thus makes carbohydrate available as source of
energy. Bilirubin is a metabolite of the heme portion of heme
proteins, mainly hemoglobin. It is excreted by the liver into
the bile and the intestine. Hemoglobin when catabolized by
the reticuleo-endothelial system is released into the blood-
stream where it binds strongly to albumin and is transported to
the liver. Upon uptake by the liver, bilirubin is conjugated with
glucuronic acid to form bilirubin mono and diglucuronide
which are water soluble metabolites. Elevations of bilirubin in
diabetic induced rats have been reported with signiﬁcant
improvement after treatment with Moringa oleifera oil[21].
Elevations in both direct and total bilirubin observed in
diabetic untreated group may be due to excessive hemolysis,
destruction of red blood cells or obstruction of the biliary
tract. The treatment groups ameliorated the elevated levels
probably due to strong tissue repair ability of the extract.
Insulin can affect the adipocytes by inhibiting lipolysis and
promoting the storage of triacylglycerol in adipocytes. Thus,
lack of it or inadequate utilization as in diabetes enhanced the
hydrolysis of triacylglycerol into diacylglycerol, unesteriﬁed
fatty acids and free glycerols[22]. Dyslipidemia observed in
diabetic state brings about inhibitory action on 3-hydroxy-3-
methylglutaryl coenzyme A reductase, a key role rate-limiting
enzyme responsible for the metabolism of cholesterol rich low
density lipid particles. Acute insulin deﬁciency initially causes
an increase in free fatty acid mobilization from adipose tissue.
High density lipoprotein (HDL) is an anti-atherogenic lipo-
protein that transports cholesterol from peripheral tissue into
the liver and thereby acts as a protective factor against coro-
nary heart disease[23]. The result showed a signiﬁcant
(P < 0.05) decrease in low density lipoprotein (LDL), total
cholesterol and triacylglycerol (TAG) levels in all diabetic
treated groups when compared with diabetic untreated group.
This might be due to the reduced hepatosynthesis of
triacylglycerol and/or reduced lipolysis as a result of extract
administration. The increased HDL (Figure 3) indicates a
reversed atherogenic risk. Because insulin is known to sup-
press very low density lipoprotein secretion, lack of this sup-
pression by deﬁcient insulin secretion in diabetes may lead to
hypertriglyceridemia, which possibly can mediate the mecha-
nism by which diabetes causes hyperlipidemia. There is a
concomitant increase in the hydrolysis of triacylglycerol from
very low density lipoprotein (VLDL) to low density lipopro-
tein as its concentration increases in circulation. The reversed
lipids (HDL, LDL, TAG, and cholesterol) in Figure 6 may be
that the hepatic LDL receptor which is increased by insulin (as
a result of extract administration) was able to clear most of the
blood cholesterol (VLDL and LDL carry most of the choles-
terol), thereby increasing HDL (Figure 6) and reversing the
atherogenic risk. In other words, reduction in the rate of
cholesterol removal from the circulation appeared to be
responsible for hypercholesterolemia observed in diabeticstate. It is therefore assumed that the ethanol extract of
C. pentandra have inhibiting effect against hyperglyceridemia
and hypercholesterolemia that are clinical features and com-
plications of diabetes.
According to Comazzi et al.[24], hematological (RBC), mean
cell volume, packed cell volume (PCV), platelet (PLT),
hemoglobin count (HGB), mean corpuscular hemoglobin
(MCH) and white blood count (WBC) complications consist
mainly of abnormalities in the functions, morphology and
metabolism of erythrocytes, leukocytes and platelets. The
primary reason for assessing the red blood cell (RBC) is to
check anemia and to evaluate normal hematopoiesis[25].
Packed cell volume (PCV) represents the volume of red
blood cell in 100 mL of blood and helps to determine, and
diagnose states of hydration, polycythemia, and degree of
anemia[26]. There was signiﬁcant decrease (P < 0.05) in all
hematological parameters (except the white blood cells that
showed an increase) of diabetic untreated group and these
were ameliorated by the administration of extract at varied
doses. Low hematological indices in diabetic untreated group
may be a result of anemia or the onset of glycosylation
process because the reactive oxygen species generated in
diabetic state has been implicated in red cell damage[27]. Both
doses of C. pentandra ethanol extract show no damaging
effect on all hematological parameters when compared to
normoglycemic.
Platelets are fragment of cells that participate in blood
clotting, and initiate repair of blood vessels, and are also
considered as acute phase reactant to infection or inﬂamma-
tion. Platelet count (PLT) showcases the precise method of
determining the degree of acute blood loss while white blood
cell count (WBC) measures the total number of white blood
cells which defend the blood against opportunistic infection.
The signiﬁcant (P < 0.05) reduction in PLT and increase in
WBC indicated in diabetic untreated group when compared to
normoglycemic is in line with the studies carried out by Edet
et al.[28]. They postulated that alloxan diabetogenesis may
cause perturbation in the bone marrow stem cells. Diabetes
induces dyslipidemia due to insulin deﬁciency or insulin
resistance because insulin has an inhibitory action on 3-
hydroxy-3-methylglutaryl coenzyme A reductase, a key role
rate-limiting enzyme responsible for the metabolism of
cholesterol rich low density lipid particles. Acute insulin
deﬁciency initially causes an increase in free fatty acid mobi-
lization from adipose tissue. High density lipoprotein (HDL) is
an anti-atherogenic lipoprotein. It transports cholesterol from
peripheral tissue into the liver and thereby acts as a protective
factor against coronary heart disease[29].
The ethanol leaf extract of C. pentandra had hypoglycemic
effect when orally administered to diabetic rats at varied doses. It
was also able to ameliorate the biochemical anomalies that
resulted from diabetes mellitus.
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